Navigation Links
Progesterone Treatment Cuts Preterm Birth Risk in Certain Women
Date:4/6/2011

WEDNESDAY, April 6 (HealthDay News) -- Progesterone treatment lowers the risk of preterm birth in women with a short cervix, a new study shows.

Progesterone is a naturally occurring hormone that plays an important role in maintaining pregnancy. It's believed that a short cervix -- a known risk factor for preterm birth -- may be a sign of a shortage of progesterone.

This study included 458 women with a short cervix (10-20 millimeters) who were randomly assigned to receive either a vaginal gel with progesterone or a placebo between the 19th and 23rd week of pregnancy.

The rate of preterm delivery at less than 33 weeks pregnancy was 8.9 percent for women who received the progesterone treatment and 16.1 percent for those who received the placebo. There were also differences between the two groups in rates of preterm births before 28 and 35 weeks of pregnancy.

The researchers also found that infants born to women who received the progesterone treatment had a lower rate of respiratory distress syndrome than those born to women who received the placebo -- 3 percent vs. 7.6 percent.

Women with a short cervix can be identified by ultrasound, according to the researchers.

The study, published online in the journal Ultrasound in Obstetrics and Gynecology, was conducted by researchers at the U.S. National Institute of Child Health and Human Development and colleagues at 44 medical centers worldwide. It also involved New Jersey-based Columbia Laboratories Inc, which makes a progesterone gel.

In the United States, preterm delivery is a significant problem, with 12.8 percent of infants born preterm annually, according to the March of Dimes.

Preterm infants, or "preemies," are at increased risk for death in the first year of life, the March of Dimes has reported, as well as respiratory difficulties, cerebral palsy, learning disabilities, blindness and deafness.

More information

The
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories CRINONE(R) Progesterone Gel Product Line
2. Progesterone is effective for hot flash treatment and provides an alternative to estrogen
3. Despite Treatment, Employees with Depression Generate Higher Absentee Costs, According to Thomson Reuters Study
4. Women More Likely to Fail Treatment for Atrial Fibrillation
5. Social Anxiety and Panic - Alternative Treatment to Drugs and Therapy
6. Neuroimaging study may pave way for effective Alzheimers treatments
7. Nanofilm Introduces Clarity Defog It™ Anti Fog Treatment and EcoClens™ Eco-Friendly Lens Cleaner at Vision Expo East
8. Many veterans not getting enough treatment for PTSD
9. Scott & White Memorial Hospital uses device to revolutionize treatment of traumatic aortic injury
10. Allegheny General Hospital Study Demonstrates Safety and Potential Efficacy of Oral Allergy Treatment
11. Charging less for more effective treatments could reduce health care costs while improving health
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Progesterone Treatment Cuts Preterm Birth Risk in Certain Women
(Date:5/22/2013)... 22, 2013 GS1 has honored Tim ... Company, and Danny Wegman, CEO, Wegmans Food Markets, ... General Assembly and Global Leadership Summit, held May 20-23 ... were recognized for their outstanding contributions to the advancement ... used supply chain standards globally. , “The leadership, ...
(Date:5/22/2013)... and teens exposed to radiation during CT scans are ... a large, long-term study. The risks, however, are ... who each had one CT scan, only about six ... years, according to researchers from Australia and Europe. ... to patients when making decisions about CT (computed tomography) ...
(Date:5/22/2013)... This news release is available in German . ... Forschungsgemeinschaft (DFG, German Research Foundation) is establishing 11 new ... in Germany. This decision was made by the relevant ... euros has been awarded to the new programmes for ... In addition to the 11 new Research Training Groups, ...
(Date:5/22/2013)... to finish the last ounce in their bottle might be ... burn off, a bad habit remains. , Brigham Young University ... obesity at 24 months of age strongly traces back to ... it puts you on a trajectory where you are likely ... an adult," said Forste. "That,s a big concern." , The ...
(Date:5/22/2013)... May 22, 2013 The new 13-valent pneumococcal ... the previous version used prior to 2010, the 7-valent ... study published today in Vaccine . , The ... beginning in 2010 after a series of trials. These ... range of pneumococcal types than the previously used PCV7, ...
Breaking Medicine News(10 mins):Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 2Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 3Health News:Children Who Have CT Scans May Face Higher Cancer Risk 2Health News:DFG establishes 11 new research training groups 2Health News:DFG establishes 11 new research training groups 3Health News:DFG establishes 11 new research training groups 4Health News:DFG establishes 11 new research training groups 5Health News:Overeating learned in infancy, study suggests 2Health News:Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine 2
... a leading global clinical,research organization, is pleased to ... at the JCAHPO annual continuing education,program. Diana who ... Cannula, worked in ophthalmic practice for several years,prior ... (CRA). The,meeting will take place in New Orleans, ...
... 1 The makers of the WaveSense line ... Claudio,Carboni, formerly of Menarini Diagnostics, has joined as ... WaveSense Europe will,distribute the company,s high accuracy, WaveSense ... market both directly and through local,partners. Carboni ...
... MINNEAPOLIS /ST. PAUL (October 31, 2007) According to new ... information in most cases to apply a policy and ... the information. Medicare appears reluctant to aggressively enforce ... are inconsistent with scientific evidence. , By law, Medicare ...
... Video Component Enables Users to Upload Video Confessions/ ... on newfaceofresearch.com for Peer-to-Peer Viewing, PHILADELPHIA and ... Thomson Corporation (NYSE: TOC ; TSX: TOC) ... research and,business communities, today announced the launch of ...
... providing all current services, invest $20 million in ... ... Calif., Oct. 31 Prime Healthcare Services,Inc. (PHS), the owner ... today that Prime Healthcare Centinela, one,of its subsidiaries, has acquired ...
... Health,Services (MHS), a not-for-profit health care system with ... that it has selected,Integrated Healthcare Holdings, Inc. (IHHI) ... a partially physician-owned publicly traded hospital management,company, owns ... a total of,770 beds, 2787 employees and 1725 ...
Cached Medicine News:Health News:Diana Hatsis of Chiltern Will Present at the Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) 35th Annual Continuing Education Program Held in Conjunction With the American Academy of Ophthalmology (AAO) Annual Meeting 2Health News:Ex-Head of Menarini Diabetes Unit Launches WaveSense Europe 2Health News:U of M study: Medicare lacks tools, incentives to enforce evidence-based coverage policies 2Health News:Thomson Scientific Launches 'Confessions ... of a User' Campaign Asking 'Are You the New Face of Research?' 2Health News:Prime Healthcare Services Acquires Centinela Hospital Medical Center 2Health News:Prime Healthcare Services Acquires Centinela Hospital Medical Center 3Health News:Prime Healthcare Services Acquires Centinela Hospital Medical Center 4Health News:Memorial Health Services Announces Sale of Anaheim Memorial Medical Center 2
(Date:5/22/2013)... , May 22, 2013  Avanir Pharmaceuticals, Inc. (NASDAQ: ... present an overview of the company at the following conferences. ... , Presentation date: Wednesday May 29, 2013 , ... 2013 Global Healthcare Conference , Presentation date: Wednesday June ... A live webcast and 30-day ...
(Date:5/22/2013)... Mass. , May 22, 2013  Flagship ... firm focused on healthcare and sustainability, today announced ... as a Senior Partner. In this role, ... to portfolio companies. In addition to ... Mr. Bancel also serves as President and Chief ...
(Date:5/22/2013)... , May 22, 2013  Grifols, a global ... , presented results from a study demonstrating that a ... Inhibitor [Human]) increased levels of the alpha 1 ... to levels that are considered within the normal range ... condition in which low levels of the alpha 1 ...
Breaking Medicine Technology:Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4
... Elusys Therapeutics, Inc.,(Elusys), a privately held biopharmaceutical ... life-threatening infectious,diseases, today announced it has been ... development of Anthim(TM), the company,s late-stage anthrax,therapeutic. ... or in part with Federal,funds from the ...
... Trial Aims to Treat Renal Artery Obstructions and Lower ... Pressure in Patients Not Responding to Medication, ... today announced enrollment of the first patient in HERCULES ... and,Safety), a U.S. clinical trial designed to evaluate the ...
Cached Medicine Technology:Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Company's Anthrax Therapeutic 2Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis 2Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis 3
Castroviejo microscopic needle holder...
Dilator...
Microscopic scissors, curved...
Microscopic needle holder, curved...
Medicine Products: